Home » Topics » BioWorld Science

BioWorld Science
RSS

Allelix: Q1 1998 highlights

Jan. 28, 1998

Antihypertensive efficacy described for Novartis' dual ACE/NEP inhibitor

Jan. 28, 1998

EUK-134 effective in animal model of stroke

Jan. 28, 1998

In vivo efficacy reported for angiotensin II blocker

Jan. 28, 1998

New test for cardiovascular disease risk assessment from Myriad Genetics

Jan. 28, 1998

FDA panel recommends approval of Verdia

Jan. 28, 1998

BioMarin's lead enzyme replacement therapy enters clinical trials

Jan. 28, 1998

Anti-TNF strategy in MS treatment should be reconsidered

Jan. 28, 1998

Rate-independent profile of antiarrhythmic agent suggests improved therapeutic potential

Jan. 28, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...